Category: D.C. Diagnosis

STAT+: Democrats keep IVF in the spotlight with another Senate vote

September 17, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicine, policy, Politics, reproductive health, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: How efforts to cancel medical debt could wind up benefitting hospitals

September 12, 2024 STAT Off Biotech, D.C. Diagnosis, FDA, Health, hospitals, Human Health, Life Sciences, Medicine, NIH, policy, Politics, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

The health care issues to watch in tonight’s presidential debate between Kamala Harris and Donald Trump

September 10, 2024 STAT Off Biotech, D.C. Diagnosis, Health, Human Health, Life Sciences, Medicine, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Oprah, Walz and other Democrats hammer reproductive freedom message at DNC

August 22, 2024 STAT Off abortion, Biotech, Congress, D.C. Diagnosis, doctors, Human Health, Life Sciences, Medicine, policy, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Abortion rights and drug pricing program take spotlight at first night of DNC

August 20, 2024 STAT Off abortion, Biotech, D.C. Diagnosis, drug pricing, hospitals, Human Health, Life Sciences, Medicine, policy, Politics, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

The politics of mifepristone in the 2024 election

August 13, 2024 STAT Off abortion, addiction, Biotech, D.C. Diagnosis, drug prices, FDA, Health, Human Health, Life Sciences, Medicare, Medicine, policy, psychedelics, reproductive health, research, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Picking apart health care lobbying, from Grindr to Lipton Tea

July 30, 2024 STAT Off Biotech, D.C. Diagnosis, Health, Human Health, Life Sciences, Medicine, policy, Politics, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: The state pharma’s targeting this election cycle

July 25, 2024 STAT Off Biotech, D.C. Diagnosis, health insurance, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, physicians, policy, Politics, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Here come Medicare’s first negotiated drug prices

July 18, 2024 STAT Off Biotech, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: The pharmaceutical industry keeps losing Washington friends

July 9, 2024 STAT Off Biotech, campaigns, Congress, D.C. Diagnosis, hospitals, Human Health, Life Sciences, Medicine, Pharmaceuticals, Politics, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Making sense of the debate’s health care debate

July 2, 2024 STAT Off abortion, Biotech, campaigns, D.C. Diagnosis, Human Health, Joe Biden, Life Sciences, Medicare, Medicine, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Key health care topics to watch out for at the Biden-Trump debate

June 27, 2024 STAT Off Biotech, Business, D.C. Diagnosis, drug pricing, government agencies, Health, Human Health, legal, Life Sciences, Medicine, policy, Politics, Science and Research, Supreme Court, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Senators push Medicare for a PET scan pay bump

June 25, 2024 STAT Off Alzheimer's disease, Biotech, Congress, D.C. Diagnosis, diagnostics, Exclusive, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

A new era for NIH

June 18, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicine, NIH, policy, Politics, research, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Does Sanders have the votes to subpoena a Novo exec?

June 13, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, policy, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

FDA says it’s getting serious about illegal vapes. It’s still likely to get a tongue lashing.

June 11, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, FDA, Human Health, Life Sciences, Medicine, policy, Science and Research, vaping

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Dark money group runs ads on China biotech bill

May 28, 2024 STAT Off advocacy, Biotech, Congress, COVID-19, D.C. Diagnosis, Human Health, Life Sciences, Medicine, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Pharma’s losing bet in New Jersey

May 23, 2024 STAT Off Biotech, biotechnology, clinical trials, Congress, D.C. Diagnosis, FDA, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research, STAT+

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

WuXi Biologics beefs up its lobbying operation

May 16, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicine, policy, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: CDC goes hard on military pets

May 9, 2024 STAT Off Biotech, CDC, Congress, COVID-19, D.C. Diagnosis, FDA, hospitals, Human Health, Life Sciences, Medicine, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

UnitedHealth’s Andrew Witty gets no pity in Congress

May 2, 2024 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, Human Health, infectious disease, insurance, Life Sciences, Medicine, policy, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

STAT+: Washington kicks into gear on H5N1

April 25, 2024 STAT Off abortion, Biotech, biotechnology, D.C. Diagnosis, H5N1 Bird Flu, Human Health, legal, Life Sciences, Medicine, policy, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

WuXi and BIO’s grip-and-grin

April 18, 2024 STAT Off Biotech, D.C. Diagnosis, Human Health, Life Sciences, Medicine, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

House looks to weaken Medicare negotiation

February 29, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, drug prices, Human Health, Life Sciences, Medicare, Medicare negotiation, Medicine, Pharmaceuticals, policy, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Colorado could cap payments for Amgen’s Enbrel

February 22, 2024 STAT Off advocacy, Biotech, CMS, Congress, D.C. Diagnosis, drug prices, FDA, hospitals, Human Health, Life Sciences, Medicare, Medicine, policy, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Should ACA plans cover weight loss drugs?

February 20, 2024 STAT Off Biotech, D.C. Diagnosis, Human Health, Life Sciences, Medicine, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

New pharma CEOs in the hot seat

February 8, 2024 STAT Off Biotech, CDC, Congress, coronavirus, D.C. Diagnosis, drug prices, Human Health, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, Politics, public health, Science and Research, vaccines, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

CDC and social media: The new misinformation war

February 6, 2024 STAT Off 340B, Biotech, CDC, CMS, Congress, D.C. Diagnosis, drug prices, HHS, hospitals, Human Health, Joe Biden, Life Sciences, Medicare, Medicine, patents, PBMs, policy, Politics, public health, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Medicare drug price negotiation’s day in court

February 1, 2024 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, drug prices, Human Health, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, research, Science and Research, STAT+, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Bernie Sanders’ showdown with pharma CEOs is coming to a head

January 25, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, health insurance, hospitals, Human Health, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, public health, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

White House pharmacy under the microscope

January 23, 2024 STAT Off Biotech, Congress, D.C. Diagnosis, Human Health, Joe Biden, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Will Congress get any health policy done this year?

January 18, 2024 STAT Off Biotech, D.C. Diagnosis, Human Health, Life Sciences, Medicine, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Health care negotiations on Capitol Hill are clear as mud

January 16, 2024 STAT Off advocacy, Biotech, CMS, Congress, D.C. Diagnosis, HHS, Human Health, Life Sciences, Medicare, Medicine, NIH, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

January 9, 2024 STAT Off Biotech, CMS, Congress, coronavirus, D.C. Diagnosis, drug prices, FDA, HHS, hospitals, Human Health, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

At JPM, how much health policy talk should we expect?

January 4, 2024 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, drug prices, Human Health, JPM 2024, Life Sciences, Medicine, Pharmaceuticals, policy, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

An ugly fight over care for the poor in Texas

January 2, 2024 STAT Off advocacy, Biotech, biotechnology, Congress, D.C. Diagnosis, health insurance, hospitals, Human Health, Life Sciences, medical school, Medicare, Medicine, Pharmaceuticals, physicians, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Diabetes ‘epidemic’ gets a Senate hearing

December 7, 2023 STAT Off advocacy, Biotech, biotechnology, Congress, D.C. Diagnosis, diabetes, HHS, Human Health, Life Sciences, Medicare, Medicine, Pharmaceuticals, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

What health policies could hitch a ride on a spending bill?

November 14, 2023 STAT Off Biotech, biotechnology, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicare, Medicine, PBMs, Pharmaceuticals, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Medicare eligibility is tripping up the GOP presidential candidates

November 9, 2023 STAT Off advocacy, Biotech, campaigns, Congress, D.C. Diagnosis, diabetes, hospitals, Human Health, Life Sciences, Medicare, Medicine, PBMs, physicians, policy, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

November 7, 2023 STAT Off Biotech, biotechnology, CMS, Congress, D.C. Diagnosis, drug prices, HHS, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Breaking down House Speaker Mike Johnson’s health care plan

October 26, 2023 STAT Off Biotech, D.C. Diagnosis, Human Health, Life Sciences, Medicine, Politics, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Robert F. Kennedy is pitching centrism on health care, even on abortion

October 10, 2023 STAT Off Biotech, campaigns, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicare, Medicine, policy, research, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

The future of health care in the House

October 5, 2023 STAT Off Biotech, campaigns, cancer, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicare, Medicine, PBMs, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Did you have Obamacare on your GOP debate bingo card?

September 28, 2023 STAT Off addiction, Biotech, campaigns, CMS, Congress, D.C. Diagnosis, drug prices, HHS, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Will a government shutdown stall Medicare drug price negotiations?

September 26, 2023 STAT Off Biotech, biotechnology, campaigns, D.C. Diagnosis, drug prices, Human Health, Life Sciences, Medicaid, Medicare, Medicare negotiation, Medicine, Pharma, Pharmaceuticals, policy, Politics, public health, research, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Senate HELP on collision course

September 21, 2023 STAT Off Biotech, Congress, COVID-19, D.C. Diagnosis, drug prices, hospitals, Human Health, Life Sciences, Medicine, nurses, Pharmaceuticals, physicians, Politics, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Is there a path forward for PEPFAR?

September 12, 2023 STAT Off Biotech, Congress, D.C. Diagnosis, drug prices, FDA, HHS, HIV/AIDS, Human Health, Life Sciences, Medicare, Medicine, patents, Politics, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

A new House health package & hospitals’ new site-neutral talking points

September 7, 2023 STAT Off Biotech, Congress, D.C. Diagnosis, drug prices, health insurance, hospitals, Human Health, Life Sciences, Medicare, Medicine, PBMs, policy, Politics, research, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…

Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis

August 24, 2023 STAT Off abortion, Biotech, campaigns, D.C. Diagnosis, drug importation, drug prices, FDA, health care policy, Human Health, Life Sciences, Medicine, Politics, research, Science and Research

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter…

FDA budget battles, prisons’ sobering Covid response & BIO’s CEO search is on

May 23, 2023 STAT Off advocacy, Biotech, biotechnology, Congress, coronavirus, D.C. Diagnosis, dementia, FDA, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, public health, Science and Research, White House

0

0

0

0

0

0

0

0

0

0

0

0

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter…